Schonfeld Strategic Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-13,900
| Closed | -$35.3K | – | 2464 |
|
2023
Q1 | $35.3K | Sell |
13,900
-8,000
| -37% | -$20.3K | ﹤0.01% | 1738 |
|
2022
Q4 | $41K | Sell |
21,900
-19,400
| -47% | -$36.3K | ﹤0.01% | 2230 |
|
2022
Q3 | $106K | Buy |
41,300
+25,200
| +157% | +$64.7K | ﹤0.01% | 2477 |
|
2022
Q2 | $31K | Sell |
16,100
-153,700
| -91% | -$296K | ﹤0.01% | 2191 |
|
2022
Q1 | $504K | Buy |
+169,800
| New | +$504K | ﹤0.01% | 1306 |
|
2018
Q4 | – | Sell |
-85,000
| Closed | -$825K | – | 1262 |
|
2018
Q3 | $825K | Sell |
85,000
-100
| -0.1% | -$971 | 0.04% | 469 |
|
2018
Q2 | $868K | Buy |
85,100
+10,100
| +13% | +$103K | 0.05% | 415 |
|
2018
Q1 | $975K | Sell |
75,000
-27,574
| -27% | -$358K | 0.07% | 324 |
|
2017
Q4 | $1.84M | Sell |
102,574
-21,314
| -17% | -$382K | 0.15% | 189 |
|
2017
Q3 | $3.11M | Sell |
123,888
-21,112
| -15% | -$530K | 0.28% | 113 |
|
2017
Q2 | $3.5M | Buy |
145,000
+75,017
| +107% | +$1.81M | 0.36% | 67 |
|
2017
Q1 | $1.35M | Buy |
+69,983
| New | +$1.35M | 0.14% | 217 |
|